Literature DB >> 25533045

Localization and expression profile of Group I and II Activators of G-protein Signaling in the kidney.

Marek Lenarczyk1, Jeffrey D Pressly, Joanna Arnett, Kevin R Regner, Frank Park.   

Abstract

Activators of G-protein Signaling (AGS) are a family of accessory proteins that were discovered as modulators of heterotrimeric G-protein subunits. The primary aim of the present study was to localize Group I and II AGS proteins and determine the renal expression profile using immunohistochemistry and quantitative RT-PCR, respectively, during normal and injured states of the kidney. Group I AGS1 was found to be predominantly localized to the proximal tubule, Group II AGS3 and AGS5 were exclusively localized to the distal tubular segments, and Group II AGS6 was ubiquitously expressed in every nephron segment of the rodent kidney. In rat kidneys following ischemia-reperfusion injury (IRI), Group I AGS1 mRNA was dramatically increased after 24 h by fivefold (P < 0.05), whereas Group II AGS3 and AGS4 mRNA was significantly decreased at the same time point (P < 0.05). No significant change in the transcript levels were detected at other time points for any of the AGS genes between control and IRI groups. In polycystic diseased kidneys, mRNA levels for AGS3, AGS4 and AGS6 was significantly increased (P < 0.05) by 75-80 % in PCK rat kidneys. The identification of Group I and II AGS mRNA and protein in the kidney may provide insight into the potential mechanism of action during normal and varying states of renal disease or injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25533045      PMCID: PMC4369180          DOI: 10.1007/s10735-014-9605-0

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  57 in total

1.  Rap1GAP regulates renal cell carcinoma invasion.

Authors:  Wan-Ju Kim; Zachary Gersey; Yehia Daaka
Journal:  Cancer Lett       Date:  2012-01-20       Impact factor: 8.679

Review 2.  Accessory proteins for G proteins: partners in signaling.

Authors:  Motohiko Sato; Joe B Blumer; Violaine Simon; Stephen M Lanier
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

Review 3.  Inherited endocrine diseases involving G proteins and G protein-coupled receptors.

Authors:  Allen M Spiegel
Journal:  Endocr Dev       Date:  2007

4.  Identification of transcription factor E3 (TFE3) as a receptor-independent activator of Gα16: gene regulation by nuclear Gα subunit and its activator.

Authors:  Motohiko Sato; Masahiro Hiraoka; Hiroko Suzuki; Yunzhe Bai; Reiko Kurotani; Utako Yokoyama; Satoshi Okumura; Mary J Cismowski; Stephen M Lanier; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2011-03-24       Impact factor: 5.157

5.  Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alpha.

Authors:  Joe B Blumer; Michael L Bernard; Yuri K Peterson; Jun-ichi Nezu; Peter Chung; Dara J Dunican; Juergen A Knoblich; Stephen M Lanier
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

6.  A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis.

Authors:  Motonobu Anai; Nobuhiro Shojima; Hideki Katagiri; Takehide Ogihara; Hideyuki Sakoda; Yukiko Onishi; Hiraku Ono; Midori Fujishiro; Yasushi Fukushima; Nanao Horike; Amelia Viana; Masatoshi Kikuchi; Noriko Noguchi; Shinichiro Takahashi; Kuniaki Takata; Yoshitomo Oka; Yasunobu Uchijima; Hiroki Kurihara; Tomoichiro Asano
Journal:  J Biol Chem       Date:  2005-03-07       Impact factor: 5.157

7.  20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism.

Authors:  Talha Akbulut; Kevin R Regner; Richard J Roman; Ellis D Avner; John R Falck; Frank Park
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-01

8.  Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC.

Authors:  Timo Rieg; Tong Tang; Shinichi Uchida; H Kirk Hammond; Robert A Fenton; Volker Vallon
Journal:  Am J Pathol       Date:  2012-11-01       Impact factor: 4.307

9.  The Ras-related protein AGS1/RASD1 suppresses cell growth.

Authors:  Govindan Vaidyanathan; Mary J Cismowski; Guoshun Wang; Timothy S Vincent; Kevin D Brown; Stephen M Lanier
Journal:  Oncogene       Date:  2004-07-29       Impact factor: 9.867

10.  Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.

Authors:  Uma Potla; Jie Ni; Justin Vadaparampil; Guozhe Yang; Jeremy S Leventhal; Kirk N Campbell; Peter Y Chuang; Alexei Morozov; John C He; Vivette D D'Agati; Paul E Klotman; Lewis Kaufman
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

View more
  10 in total

Review 1.  Activators of G protein signaling in the kidney.

Authors:  Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2015-01-27       Impact factor: 4.030

2.  Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury.

Authors:  Jeffrey D Pressly; Suni M Mustafa; Ammaar H Adibi; Sahar Alghamdi; Pankaj Pandey; Kuldeep K Roy; Robert J Doerksen; Bob M Moore; Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2017-11-29       Impact factor: 4.030

3.  Intersection of two key signal integrators in the cell: activator of G-protein signaling 3 and dishevelled-2.

Authors:  Ali Vural; Stephen M Lanier
Journal:  J Cell Sci       Date:  2020-09-04       Impact factor: 5.285

Review 4.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

5.  TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injury.

Authors:  Jeffrey D Pressly; Taketsugu Hama; Shannon O' Brien; Kevin R Regner; Frank Park
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

6.  Urinary exosomal expression of activator of G protein signaling 3 in polycystic kidney disease.

Authors:  Krishna C Keri; Kevin R Regner; Aaron T Dall; Frank Park
Journal:  BMC Res Notes       Date:  2018-06-07

7.  DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity.

Authors:  Taketsugu Hama; Prashanth Kb Nagesh; Pallabita Chowdhury; Bob M Moore; Murali M Yallapu; Kevin R Regner; Frank Park
Journal:  JCI Insight       Date:  2021-11-22

Review 8.  Accessory proteins for heterotrimeric G-proteins in the kidney.

Authors:  Frank Park
Journal:  Front Physiol       Date:  2015-08-07       Impact factor: 4.566

9.  Activator of G-protein Signaling 3 Controls Renal Epithelial Cell Survival and ERK5 Activation.

Authors:  Shauna A Rasmussen; Michelle Kwon; Jeffrey D Pressly; Joe B Blumer; Kevin R Regner; Frank Park
Journal:  J Mol Signal       Date:  2015-11-27

10.  Deciphering the potential pharmaceutical mechanism of Guzhi Zengsheng Zhitongwan on rat bone and kidney based on the "kidney governing bone" theory.

Authors:  Baojin Yao; Jia Liu; Mei Zhang; Xiangyang Leng; Daqing Zhao
Journal:  J Orthop Surg Res       Date:  2020-04-15       Impact factor: 2.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.